Historical development of health technology assessment in Thailand

International Journal of Technology Assessment in Health Care

Volumn 25, Issue SUPPL.S1, 2009, Pages 241-252

  Teerawattananon, Yot ^a   Tantivess, Sripen ^a   Yothasamut, Jomkwan ^a   Kingkaew, Pritaporn ^a   Chaisiri, Kakanang ^a  

^a MINISTRY OF PUBLIC HEALTH   (Thailand)

Author keywords

Economic evaluation; Health Intervention and Technology Assessment Program (HITAP); Health technology assessment; History; Thailand

Indexed keywords

ECONOMIC EVALUATIONS; HEALTH INTERVENTIONS; HEALTH TECHNOLOGY ASSESSMENTS; TECHNOLOGY ASSESSMENTS; THAILAND;

DECISION MAKING; ECONOMIC ANALYSIS; RESEARCH; TECHNOLOGICAL FORECASTING; TECHNOLOGY;

HEALTH;

BIOMEDICAL TECHNOLOGY ASSESSMENT; ECONOMIC EVALUATION; FINANCIAL MANAGEMENT; GOVERNMENT; HEALTH CARE DELIVERY; HEALTH CARE FINANCING; HEALTH CARE NEED; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HEALTH CARE UTILIZATION; HEALTH INSURANCE; MEDICAL RESEARCH; PUBLIC HEALTH SERVICE; REVIEW; SOCIOECONOMICS; THAILAND;

DELIVERY OF HEALTH CARE; HEALTH POLICY; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; PROGRAM DEVELOPMENT; SOCIAL CLASS; TECHNOLOGY ASSESSMENT, BIOMEDICAL; THAILAND;

EID: 75149140930     PISSN: 02664623     EISSN: 14716348     Source Type: Journal    
DOI: 10.1017/S0266462309090709     Document Type: Review

References (44)

1. BantaD, Oortwijn W. Health technology assessment and health care in the European Union. Int J Technol Assess Health Care. 2000;16:626-635. (Pubitemid 30602100)
2. Bronzino JD, Smith VH, Wade ML. Medical technology and society: An interdisciplinary perspective. Massachusetts: MIT Press; 1990.
3. Bunta D. The development of health technology assessment. Health policy. 2003;63:121-132.
4. Chongtrakul P, Sumpradit N, Yoongthong W. ISafE and the evidence-based approach for essential medicines selection in Thailand. Essent Drugs Monit. 2005;34:18-19.
5. Chuengsatiansup K, Mooksong C. Historical of medicine and public health in Thailand. Bangkok: Society and Health Institute; 2005.
6. Green A, Bennett S. Sound choices: Enhancing capacity for evidence-informed health policy. Geneva: World Health Organization; 2007.
7. Hanvoravongchai P, Letiendumrong J, Teerawattananon Y, Tangcharoensathien V. Implications of private practice in private hospitals on the caesarean section rate in Thailand. Hum Resour Health Dev J. 2000;4:1-2.
8. Harris A, Buxton M, O'Brien B, Rutten F, Drummond M. Using economic evidence in reimbursement decisions for health technologies: Experience of 4 countries. Expert Rev Pharmacoeconom Outcomes Res. 2001;1:7-12.
9. International Monetary Fund. World economic and financial surveys. Washington, DC: IMF: 2007.
10. Jindawatthana W, Hanvoravongchai P, Tangcharoensathien V. High cost medical devices in Thailand: Diffusion, utilization and access. J Health Sci. 2001;10:242-252.
11. Kapol N, Maitreemit P, Chalongsuk R, et al. Making health technology assessment information available for decision making: The development of a Thai database. J Med Assoc Thai. 2008;91(supSpl 2):S8-S10.
12. Lertpitakpong C, ChaikledkaewU, ThavorncharoensapM, et al. A determination of topics for health technology assessment in Thailand: Making decision makers involved. JMed Assoc Thai. 2008;91(Suppl 2):s100-s109.
13. Mills A. From research to knowledge to action: The dual challenge of health systems research. World Hosp Health Serv. 2004;40:18-23, 50, 51-52.
14. Ministry of Public Health of Thailand. Order of appointment from the Subcommittee for Development of the National List of Essential Medicines 3/2549. Bangkok: Ministry of Public Health of Thailand; 2006.
15. Nansunanont S, Tantivess S, Yothasamut J, Putchong C, Kongpittayachai S. The development of health technology assessment in Thailand, 1996-2006. Nonthaburi: Health Intervention and Technology Assessment; 2008. (in Thai).
16. Neumann P. Using cost-effectiveness analysis to improve health care: Opportunities and barriers. Oxford: Oxford University Press; 2005.
17. Office of National Statistics. Key statistics of Thailand. Bangkok: Office of National Statistics; 2005.
18. Office of the National Economic and Social Development Board. The 10th National Economic and Social Development Plan (2007-2010). Bangkok: Office of the National Economic and Social Development Board; 2007.
19. Office of the National Economic and Social Development Board. Poverty and income distribution. Bangkok: Office of the National Economic and Social Development Board.
20. Pitaknetinan K, Tangcharoensathien V, Supachutikul A, Bennett S, Mills A. Profit, payment and pharmaceutical practices: Perspectives from hospitals in Bangkok. Health Policy. 1999;46:179-194.
21. Pitayarangsarit S, Tangcharoensathien V. Beyond training: Thailand experiences on sustaining capacity in health policy and systems research. Nonthaburi: International Health Policy Program. 2008.
22. Prakongsai P, Tantivess S, Tangcharoensathien V. Proton radiation therapy: Is it necessary for Thailand?. Health Policy Plan J. 2002;4:8-31.
23. Tangcharoensathien V. Social health insurance: Report of a regional expert group meeting. New Delhi: World Health Organization; 2003.
24. Tangcharoensathien V, Harnvoravongchai P, Pitayarangsarit S, Kasemsup V. Health impacts of rapid economic changes in Thailand. Soc Sci Med. 2000;51:789-807
25. Tangcharoensathien V, Kasemsap V, Teerawattananon Y, et al. Universal access to renal replacement therapy in Thailand: A policy analysis.Nonthaburi: Health SystemsResearch Institute; 2005.
26. Tangcharoensathien V, Phoolcharoen W, Pitayarangsarit S, et al. The potential demand for an AIDS vaccine in Thailand. Health Policy. 2001;57:111-139.
27. Tangcharoensathien V, Tantivess S, Teerawattananon Y, Auamkul N, Jongudoumsuk P. Universal coverage and its impact on reproductive health services in Thailand. Reprod Health Matters. 2002;10:59-69.
28. Tangcharoensathien V, Vasavit J. National health accounts in Thailand: 1994-2001. Nonthaburi: International Health Policy Program; 2004.
29. Tantivess S, Teerawattananon Y, Mills A. Strengthening costeffectiveness analysis in Thailand through the establishment of the Health Intervention and Technology Assessment Program. Pharmacoeconomics, in press.
30. Tantivess S, Walt G. The role of state and non-state actors in the policy process: The contribution of policy networks to the scale-up of antiretroviral therapy in Thailand. Health Policy Plan. 2008;23:328-338.
31. Teerawattananon Y, Russell S. A difficult balancing act: Policy actors' perspectives on using economic evaluation to inform health-care coverage decisions under the universal health insurance coverage scheme in Thailand. Value Health. 2008;11(Suppl 1):S52-S60.
32. Teerawattananon Y, Russell S, Mugford M. A systematic review of economic evaluation literature in Thailand: Are the data good enough to be used by policy-makers? Pharmacoeconomics. 2007;25:467-479.
33. Teerawattananon Y, Tangcharoensathien V. Designing a reproductive health services package in the universal health insurance scheme in Thailand: Match and mismatch of need, demand and supply. Health Policy Plan. 2004;19(Suppl 1):i31-i39.
34. Teerawattananon Y, Tangcharoensathien V. Economic evaluation of the program for prevent mother-to-child HIV transmission in Thailand. Nonthaburi: Ministry of Public Health; 2002.
35. Teerawattananon Y, Tangcharoensathien V, Tantivess S, Mills A. Health sector regulation in Thailand: Recent progress and the future agenda. Health Policy. 2003;63:323-338.
36. Thai Drug System Analytical Committee. Thai drug system. Nonthaburi: The Food and Drug Administration; 2002.
37. TheDrugMedical Supply Information Center (DMSIC). Prices of drugs and medical devices. Nonthaburi: The Ministry of Public Health; 2001.
38. The National Drug Committee. National list of essential medicines 2008. Nonthaburi: The Ministry of Public Health; 2008.
39. Tisayaticom K, Patcharanarumo W, Tangcharoensathien V, Tiampriwan A, Sumalee H. SHA-Based health accounts in Asia Pacific: Country studies Thailand. Nonthaburi: International Health Policy Program; 2005.
40. Tomson G, Sundbom R. The technology assessment and social security in Thailand (TASSIT) project report. Stockholm: Division of International Health (IHCAR), Karolinska Institute; 1999.
41. Towse A,Mills A, Tangcharoensathien V. Learning from Thailand's health reforms. BMJ. 2004;328:103-105.
42. Wells J, Cheong-Leen C. NICE appraisals should be everybody's business. BMJ. 2007;334:936-938.
43. Wibulpolprasert S. The need for guidelines and the use of economic evidence in decision-making in Thailand: Lessons learnt from the development of the national list of essential drugs. J Med Assoc Thai. 2008;91(Suppl 2):s1-s3.
44. Wibulpolprasert S, ed. Thailand health profile: 2001-2004. Bangkok: Printing Press, Express Transportation Organization; 2005.